[1]JournalofMedicinalChemistry,1993,vol.36,p.243-248
[1]CurrentPatentAssignee:CHIROGATEINTERNATIONAL,INC.-EP2837621,2015,A1
[2]CurrentPatentAssignee:CHIROGATEINTERNATIONAL,INC.-US2015/51410,2015,A1
[3]Zhu,Kejie;Hu,Sha;Liu,Minjie;Peng,Haihui;Chen,Fen-Er[AngewandteChemie-InternationalEdition,2019,vol.58,#29,p.9923-9927][Angew.Chem.,2019,vol.131,#29,p.10028-10032,5]
[4]Sasane,SachinA.;Bhise,NanduB.;Singh,GirijP.;Joseph,Alex;Shenoy,GauthamG.[SyntheticCommunications,2019,vol.49,#18,p.2350-2356]
[5]Hayashi,Yujiro;Umekubo,Nariyoshi[EuropeanJournalofOrganicChemistry,2020,vol.2020,#39,p.6221-6227]
Title: Pauly A, et al. In vitro and in vivo comparative toxicological study of a new preservative-free latanoprost formulation. Invest Ophthalmol Vis Sci. 2012 Dec 13;53(13):8172-80.